Cormorant Asset Management’s Cullinan Oncology CGEM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,125,000	Closed	-$19.6M	–	46
2024 Q2	$19.6M	Buy	+1,125,000	New	+$19.6M	1.13%	26
2021 Q2	–	Sell	-150,000	Closed	-$6.25M	–	107
2021 Q1	$6.25M	Buy	+150,000	New	+$6.25M	0.14%	83